Clinical Trial Update: HS-IT101 Injection in the Treatment of Advanced Melanoma [Phase 1]

View source ↗

Summary

This clinical trial update reports Phase 1 testing of HS-IT101 injection for advanced melanoma, with enrollment ongoing by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• HS-IT101

Snippet

Sponsor: Qingdao Sino-Cell Biomedicine Co., Ltd. | Conditions: Advanced Melanoma | Phase 1 | Status: ENROLLING_BY_INVITATION